Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | KDR |
| Variant | A1065T |
| Impact List | missense |
| Protein Effect | gain of function - predicted |
| Gene Variant Descriptions | KDR (VEGFR2) A1065T lies within the protein kinase domain of the Kdr (Vegfr2) protein (UniProt.org). A1065T results in constitutive tyrosine autophosphorylation (PMID: 19723655), and therefore, is predicted to lead to a gain of Kdr (Vegfr2) protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
KDR mutant KDR act mut KDR A1065T |
| Transcript | NM_002253.4 |
| gDNA | chr4:g.55089802C>T |
| cDNA | c.3193G>A |
| Protein | p.A1065T |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_002253.3 | chr4:g.55089802C>T | c.3193G>A | p.A1065T | RefSeq | GRCh38/hg38 |
| NM_002253 | chr4:g.55089802C>T | c.3193G>A | p.A1065T | RefSeq | GRCh38/hg38 |
| NM_002253.4 | chr4:g.55089802C>T | c.3193G>A | p.A1065T | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| KDR A1065T | Advanced Solid Tumor | sensitive | Sunitinib | Preclinical | Actionable | In a preclinical study, cells expressing KDR A1065T were sensitive to Sutent (sunitinib) in culture (PMID: 19723655). | 19723655 |